Evidence map›Paper›PMID 35143297›Full record

ArticleScience (New York, N.Y.)2022

Caloric restriction in humans reveals immunometabolic regulators of health span.

O Spadaro, Y Youm, I Shchukina, S Ryu, S Sidorov, A Ravussin, K Nguyen, E Aladyeva, A N Predeus, S R Smith and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 188 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
188citing papers in PubMed, 2 pooled it
104.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

188 citing papers in PubMed, 2 syntheses or guidelines pooled it, 288 citations in OpenAlex.

  1. Interventions that prolong multidimensional healthspan in humans: a systematic review of randomized controlled trials.The journals of gerontology. Series A, Biological sciences and medical sciences · 2026
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Epigenome-wide Association Study Analysis of Calorie Restriction in Humans, CALERIETM Trial Analysis.The journals of gerontology. Series A, Biological sciences and medical sciences · 2022
    Trial
  9. Phospholipases: Where Do We Stand?Methods in molecular biology (Clifton, N.J.) · 2027
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. AlphaGenome Atlas:medRxiv : the preprint server for health sciences · 2026
    Article
  15. The Hallmarks of Aging: From Molecular Mechanisms to Clinical Translation.International journal of molecular sciences · 2026
    Review
  16. Risk Factors for Secondary Immunodeficiency in the Aged.The journal of allergy and clinical immunology. In practice · 2026
    Review
  17. Review
  18. Article
  19. What Do We Know About Immune System Aging from Human and Animal Studies?International journal of molecular sciences · 2026
    Review
  20. Review

128 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

O SpadaroDepartment of Pathology, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0001-7005-706X
Y YoumDepartment of Pathology, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0002-8098-8527
I ShchukinaDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
S RyuDepartment of Pathology, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0001-6353-8789
S SidorovDepartment of Pathology, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0002-1730-265X
A RavussinDepartment of Pathology, Yale School of Medicine, New Haven, CT, USA.
K NguyenDepartment of Pathology, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0002-5888-4350
E AladyevaDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
A N PredeusDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-2750-1599
S R SmithTranslational Research Institute for Metabolism and Diabetes, AdventHealth, Orlando, FL, USA.
E RavussinPennington Biomedical Research Center, LSU, Baton Rouge, LA, USA.ORCID 0000-0003-2129-547X
C GalbanDepartment of Radiology, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA.ORCID 0000-0001-5596-7487
M N ArtyomovDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-1133-4212
V D DixitDepartment of Pathology, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0002-5341-6494
Yale University · USWashington University in St. Louis · USAdventHealth Orlando · USMichigan Medicine · USPennington Biomedical Research Center · US

Funding

Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Brian N Finck · 1999 to 2026
$30.2M
Research BaseP30DK072476 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2005 to 2026
$26.5M
The role of AgRP/Auga-ALK pathway in FGF21's brain action on agingP01AG051459 · NIA · YALE UNIVERSITY · PI VISHWA DEEP DIXIT · 2016 to 2026
$25.7M
Coordinating Center for CALERIEU01AG022132 · NIA · DUKE UNIVERSITY · PI KRAUS, WILLIAM E · 2002 to 2013
$24.9M
Metabolic Adaptations to Two Year Caloric RestrictionU01AG020478 · NIA · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI RAVUSSIN, ERIC · 2002 to 2008
$13.4M
Caloric Restriction and Aging in HumansU01AG020487 · NIA · WASHINGTON UNIVERSITY · PI HOLLOSZY, JOHN O. · 2001 to 2009
$8.9M
Dietary Energy Restriction and Metabolic Aging in HumansU01AG020480 · NIA · TUFTS UNIVERSITY BOSTON · PI ROBERTS, SUSAN B · 2002 to 2008
$8.2M
Impact of Ketone Metabolites on Inflammasome Deactivation in GoutR01AR070811 · NIAMS · YALE UNIVERSITY · PI DIXIT, VISHWA DEEP · 2017 to 2021
$1.8M
Impact of Calorie Restriction on Thymopoiesis in HumansR01AG031797 · NIA · YALE UNIVERSITY · PI DIXIT, VISHWA DEEP · 2008 to 2015
$1.2M
Impact of CR on inflammasome driven immune-metabolic interactions.R01AG045712 · NIA · YALE UNIVERSITY · PI DIXIT, VISHWA DEEP · 2013 to 2014
$525k
NIAMS NIH HHS R01 AR070811NIA NIH HHS P01 AG051459NIA NIH HHS R01 AG031797NIA NIH HHS R01 AG045712NIA NIH HHS U01 AG020478NIA NIH HHS U01 AG020480NIA NIH HHS U01 AG020487NIA NIH HHS U01 AG022132NIDDK NIH HHS P30 DK056341NIDDK NIH HHS P30 DK072476
6 · The paper itself

Abstract

The extension of life span driven by 40% caloric restriction (CR) in rodents causes trade-offs in growth, reproduction, and immune defense that make it difficult to identify therapeutically relevant CR-mimetic targets. We report that about 14% CR for 2 years in healthy humans improved thymopoiesis and was correlated with mobilization of intrathymic ectopic lipid. CR-induced transcriptional reprogramming in adipose tissue implicated pathways regulating mitochondrial bioenergetics, anti-inflammatory responses, and longevity. Expression of the gene

Indexed as

Caloric RestrictionInflammation1-Alkyl-2-acetylglycerophosphocholine EsteraseAdipose TissueAdultAgingAnimalsDown-RegulationEnergy MetabolismFemaleHumansImmune SystemInflammasomesLongevityLymphopoiesisMacrophages1-Alkyl-2-acetylglycerophosphocholine EsteraseInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, mousePLA2G7 protein, humanPla2g7 protein, mouse

Identifiers

PMID35143297
PMCPMC10061495
OpenAlexW4211096034

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.